6.1. Advances in the Management of Skin Cancer

  1. Sheila M. F. Torres2,
  2. Linda A. Frank3 and
  3. Ann M. Hargis4
  1. Pamela D. Martin and
  2. David J. Argyle

Published Online: 15 APR 2013

DOI: 10.1002/9781118644317.ch24

Advances in Veterinary Dermatology, Volume 7

Advances in Veterinary Dermatology, Volume 7

How to Cite

Martin, P. D. and Argyle, D. J. (2013) Advances in the Management of Skin Cancer, in Advances in Veterinary Dermatology, Volume 7 (eds S. M. F. Torres, L. A. Frank and A. M. Hargis), John Wiley & Sons, Ltd, Oxford, UK. doi: 10.1002/9781118644317.ch24

Editor Information

  1. 2

    College of Veterinary Medicine, University of Minnesota, St Paul, Minnesota, USA

  2. 3

    College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, USA

  3. 4

    DermatoDiagnostics, Edmonds, Washington, and Department of Comparative Medicine, School of Medicine, University of Washington, Seattle, Washington, USA

Author Information

  1. Royal (Dick) School of Veterinary Studies and Roslin Institute, Easter Bush, Midlothian EH25 9RG, UK

Publication History

  1. Published Online: 15 APR 2013
  2. Published Print: 14 MAY 2013

ISBN Information

Print ISBN: 9781118644874

Online ISBN: 9781118644317

SEARCH

Keywords:

  • skin cancer;
  • receptor tyrosine kinase;
  • cognate ligands;
  • cell proliferation;
  • squamous cell carcinoma

Summary

This chapter contains sections titled:

  • Introduction

  • Receptor tyrosine kinase inhibitors

  • Retinoids

  • Toll-like receptor agonists

  • Histone deacetylase inhibitors

  • BRAF inhibitors

  • Xenogeneic DNA vaccine for canine melanom

  • Monoclonal antibodies

  • Monoclonal antibodies in the treatment of skin cancer

  • Identifying appropriate targets

  • The hurdles to clinical advancement

  • Conclusions